Apyx Medical Corporation (APYX) vs MaxCyte, Inc. (MXCT)
Apyx Medical Corporation and MaxCyte, Inc. are both Medical Devices companies. Apyx Medical Corporation and MaxCyte, Inc. are of similar size ($122.8M and $119.2M). Apyx Medical Corporation grew revenue faster over the last twelve months: 25.6% against −13.2%. Apyx Medical Corporation has the higher net margin (−14.8% vs −114.8%) and the higher return on invested capital (−11.8% vs −49.2%). Across the 18 metrics below, Apyx Medical Corporation leads on 12 and MaxCyte, Inc. on 6.
Valuation
Profitability
| Metric | APYX | MXCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.50% | 79.23% | 56.01% |
| Operating margin | (6.06%) | (134.59%) | (15.03%) |
| Net margin | (14.78%) | (114.77%) | (20.40%) |
| Free cash flow margin | (18.91%) | (76.14%) | (7.24%) |
| Return on equity | (93.11%) | (20.39%) | (15.32%) |
| Return on assets | (14.48%) | (17.62%) | (19.72%) |
| Return on invested capital | (11.76%) | (49.23%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack